Evidence map›Paper›PMID 20302320›Full record

ArticleThe journal of physical chemistry. B2010

Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.

Dianlu Jiang, Xiangjun Li, Lin Liu, Gargey B Yagnik, Feimeng Zhou

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Evaluation of a New Methylimidazole-Containing Thiosemicarbazone as a CuChemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Ascorbic acid modulates the structure of theFrontiers in microbiology · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Dual roles of tau R peptides on Cu(II)/(I)-mediated reactive oxygen species formation.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2021
    Article
  16. Fate of model complexes with monocopper center towards the functional properties of type 2 and type 3 copper oxidases.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dianlu JiangDepartment of Chemistry and Biochemistry, California State University, Los Angeles, Los Angeles, California 90032, USA.
Xiangjun Li
Lin Liu
Gargey B Yagnik
Feimeng Zhou
California State University Los Angeles · US

Funding

NOVEL DRUG DESIGN AND HIGH THROUGHPUT SCREENINGP20MD001824 · NIMHD · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI MODARRES, ALI · 2005 to 2009
$4.4M
Alpha-Synuclein-Metal Complexes and Oxidative Stress in Parkinson's DiseaseSC1NS070155 · NINDS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI ZHOU, FEIMENG · 2009 to 2012
$1.4M
NIMHD NIH HHS P20 MD001824NINDS NIH HHS SC1 NS070155NINDS NIH HHS SC1NS070155
6 · The paper itself

Abstract

A forefront of the research on Alzheimer's disease (AD) is the interaction of amyloid beta (Abeta) peptides with redox metal ions (e.g., Cu(II), Fe(III), and Fe(II)) and the biological relevance of the Abeta-metal complexes to neuronal cell loss and homeostasis of essential metals and other cellular species. This work is concerned with the kinetic and mechanistic studies of the ascorbic acid oxidation reaction by molecular oxygen that is facilitated by Cu(II) complexes with Abeta(1-16), Abeta(1-42), and aggregates of Abeta(1-42). The reaction rate was found to linearly increase with the concentrations of Abeta-Cu(II) and dissolved oxygen and be invariant with high ascorbic acid concentrations. The rate constants were measured to be 117.2 +/- 15.4 and 15.8 +/- 2.8 M(-1) s(-1) at low (<100 muM) and high AA concentrations, respectively. Unlike free Cu(II), in the presence of AA, Abeta-Cu(II) complexes facilitate the reduction of oxygen by producing H(2)O(2) as a major product. Such a conclusion is drawn on the basis that the reaction stoichiometry between AA and O(2) is 1:1 when the Abeta concentration is kept at a much greater value than that of Cu(II). A mechanism is proposed for the AA oxidation in which the oxidation states of the copper center in the Abeta complex alternates between 2+ and 1+. The catalytic activity of Cu(II) toward O(2) reduction was found to decrease in the order of free Cu(II) > Abeta(1-16)-Cu(II) > Abeta(1-42)-Cu(II) > Cu(II) complexed by the Abeta oligomer/fibril mixture > Cu(II) in Abeta fibrils. The finding that Cu(II) in oligomeric and fibrous Abeta aggregates possesses considerable activity toward H(2)O(2) generation is particularly significant, since in senile plaques of AD patients the coexisting copper and Abeta aggregates have been suggested to inflict oxidative stress through the production of reactive oxygen species (ROS). Although Cu(II) bound to oligomeric and fibrous Abeta aggregates is less effective than free Cu(II) and the monomeric Abeta-Cu(II) complex in producing ROS, in vivo the Cu(II)-containing Abeta oligomers and fibrils might be more biologically relevant given their stronger association with cell membranes and the closer proximity of ROS to cell membranes.

Indexed as

Protein MultimerizationAmyloid beta-PeptidesAntioxidantsAscorbic AcidCopperElectrochemical TechniquesHumansHydrogen PeroxideOxidation-ReductionOxygenPeptide FragmentsReactive Oxygen SpeciesSpectrophotometry, AtomicAmyloid beta-Peptidesamyloid beta-protein (1-42)AntioxidantsAscorbic AcidCopperHydrogen PeroxideOxygenPeptide FragmentsReactive Oxygen Species

Identifiers

PMID20302320
PMCPMC2878184
OpenAlexW2088616035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.